Brooks Gabriel's Form 4 filing
Solid Biosciences Inc. (SLDB) · filed Oct 21, 2025
- Accession no.
- 0001193125-25-245090
- Filed
- Oct 21, 2025
- Trade date
- Oct 18-20, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $17.3K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brooks GabrielCIK 0001997809 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2025 | Common Stock | MOption exerciseAcquired | +9,750 | –F1 | – | 36,714 | Direct | |
| Oct 20, 2025 | Common Stock | SSaleDisposed | −2,895 | $5.96 | −$17,254.2 | 33,819 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2025 | Common Stock | MOption exerciseDisposed | −9,750 | $0.00 | $0 | 19,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.